79 related articles for article (PubMed ID: 16514616)
1. Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma.
Meany HJ; Gidvani VK; Minniti CP
Pediatr Blood Cancer; 2007 Apr; 48(4):399-402. PubMed ID: 16514616
[TBL] [Abstract][Full Text] [Related]
2. 18FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma: long-term results.
Rigacci L; Castagnoli A; Dini C; Carpaneto A; Matteini M; Alterini R; Carrai V; Nassi L; Bernardi F; Pieroni C; Bosi A
Oncol Rep; 2005 Nov; 14(5):1209-14. PubMed ID: 16211287
[TBL] [Abstract][Full Text] [Related]
3. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma.
Rhodes MM; Delbeke D; Whitlock JA; Martin W; Kuttesch JF; Frangoul HA; Shankar S
J Pediatr Hematol Oncol; 2006 May; 28(5):300-6. PubMed ID: 16772881
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
5. Routine use of PET scans after completion of therapy in pediatric Hodgkin disease results in a high false positive rate.
Levine JM; Weiner M; Kelly KM
J Pediatr Hematol Oncol; 2006 Nov; 28(11):711-4. PubMed ID: 17114956
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography scanning in the assessment of patients with lymphoma.
Foo SS; Mitchell PL; Berlangieri SU; Smith CL; Scott AM
Intern Med J; 2004 Jul; 34(7):388-97. PubMed ID: 15271172
[TBL] [Abstract][Full Text] [Related]
8. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Lee AI; Zuckerman DS; Van den Abbeele AD; Aquino SL; Crowley D; Toomey C; Lacasce AS; Feng Y; Neuberg DS; Hochberg EP
Cancer; 2010 Aug; 116(16):3835-42. PubMed ID: 20564135
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
Rigacci L; Puccini B; Zinzani PL; Biggi A; Castagnoli A; Merli F; Balzarotti M; Stelitano C; Spina M; Vitolo U; Stefoni V; Levis A; Gotti M; Rosaria S; Maria SP; Bosi A; Gallamini A
Am J Hematol; 2015 Jun; 90(6):499-503. PubMed ID: 25720750
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study.
Mocikova H; Obrtlikova P; Vackova B; Trneny M
Ann Oncol; 2010 Jun; 21(6):1222-1227. PubMed ID: 19901011
[TBL] [Abstract][Full Text] [Related]
13. Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
Farina L; Rezzonico F; Spina F; Dodero A; Mazzocchi A; Crippa F; Alessi A; Dalto S; Viviani S; Corradini P
Biol Blood Marrow Transplant; 2014 Dec; 20(12):1982-8. PubMed ID: 25240818
[TBL] [Abstract][Full Text] [Related]
14. Do Deauville Scores Improve the Clinical Utility of End-of-Therapy FDG PET Scans for Pediatric Hodgkin Lymphoma?
Sedig LK; Bailey JJ; Wong KK; Brown RKJ; Kaminski MS; Hutchinson RJ
AJR Am J Roentgenol; 2019 Feb; 212(2):456-460. PubMed ID: 30476458
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between conventional imaging methods and positron emission tomography in the treatment of Hodgkin's lymphoma].
Móciková H; Marková J; Bĕlohlávek O; Cáp F; Cermák F; Feltl D; Kozák T
Cas Lek Cesk; 2004; 143(7):476-9; discussion 479-80. PubMed ID: 15373291
[TBL] [Abstract][Full Text] [Related]
16. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations].
Wickmann L; Lüders H; Dörffel W
Klin Padiatr; 2003; 215(3):146-50. PubMed ID: 12778354
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Becherer A; Mitterbauer M; Jaeger U; Kalhs P; Greinix HT; Karanikas G; Pötzi C; Raderer M; Dudczak R; Kletter K
Leukemia; 2002 Feb; 16(2):260-7. PubMed ID: 11840293
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gallium and PET scans at diagnosis and follow-up of pediatric patients with Hodgkin lymphoma.
Hines-Thomas M; Kaste SC; Hudson MM; Howard SC; Liu WA; Wu J; Kun LE; Shulkin BL; Krasin MJ; Metzger ML
Pediatr Blood Cancer; 2008 Aug; 51(2):198-203. PubMed ID: 18428430
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of positron emission tomography using fluorine-18-fluorodeoxyglucose in patients treated for malignant lymphoma.
Cremerius U; Fabry U; Neuerburg J; Zimny M; Bares R; Osieka R; Büll U
Nuklearmedizin; 2001 Feb; 40(1):23-30. PubMed ID: 11373935
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative and qualitative evaluation of the interim PET/CT in lymphoma treatment in the prediction of complete metabolic response].
Pilkington Woll JP; García Vicente AM; Talavera Rubio MP; Palomar Muñoz AM; Jiménez Londoño G; León Martín A; Calle Primo C; Soriano Castejón AM
Rev Esp Med Nucl Imagen Mol; 2013 Mar; 32(2):70-6. PubMed ID: 22759992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
